CMS

CMS changes impacting primary care for the better
CMS changes impacting primary care for the betterA look at how Medicare is reforming primary care payment.
Opioid prescription limits gain supportA pharmacist organization is among the supporters of a new Medicare Part D proposal, which calls for a 7-day supply limit on opioid prescriptions.
Five Things that Change the Quality Measurement and Reporting GameMake the rules work for, rather than, against you by relying on these five critical capabilities.
CMS Proposes Part D Opioid Limits, Pharmacy Reacts
CMS Proposes Part D Opioid Limits, Pharmacy ReactsPharmacy groups are praising new Medicare Part D opioid limits.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy ChangesHow are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.
Six things to know about CMS' new bundled payment modelCMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Despite hype, private payers slow to adopt oncology value-based modelsOncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic predictions.
Trump’s impact on ACA enrollment: What you need to knowHow did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.
New DIR Proposal Supported by Chains, Pharmacy Organizations
New DIR Proposal Supported by Chains, Pharmacy OrganizationsCMS is considering big changes to DIR fees and pharmacists are excited.
Three ways healthcare executives can uncover consumers at risk for fluWith influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.